MRA-1 – COMPREHENSIVE RESEARCH PEPTIDE FOR INCRETIN AND METABOLIC SIGNALING STUDIES
Scientific Overview of MRA-1
MRA-1 is a synthetic analog of human glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in metabolic and endocrine signaling. It is structurally modified with substitutions that increase stability and resistance to enzymatic degradation, allowing for extended half-life in research models.
In in-vitro and in-vivo studies, GLP-1 analogs have been evaluated for their effects on several biochemical and physiological pathways, including:
- GLP-1 Receptor Binding and Signal Transduction– investigation of receptor affinity and cyclic AMP–mediated mechanisms (Knudsen et al., 2000)
- Metabolic and Endocrine Regulation – study of glucose homeostasis and pancreatic beta-cell signaling in experimental systems (Marathe et al., 2020)
- Molecular Stability and Peptide Modifications – examination of acylation and D-amino acid substitutions for enhanced duration of action (Lau et al., 2015)
GLP-1 is utilized in biochemical and pharmacological research to explore incretin-based pathways and peptide stability mechanisms relevant to endocrine regulation.
*This peptide is intended solely for laboratory research use. It is not approved for human consumption or therapeutic application.
